Skip to main content

Closed

ENTX: Entera Bio Ltd. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+0.0% / yr

Operating margin0.0%

ROIC-106.5%

Financially safe

Stretched

Debt / equity0.04×

Interest coverage0.0×

Current ratio7.93×

Entera Bio Ltd.

ENTXNASDAQ Capital Market·USD·Closed

Entera Bio Ltd.

ENTXNASDAQ·USD·Closed

$2.99

+1.36%

$2.99

+$0.04 (1.36%)

52W Range

63thpctl

Volume

0.42×avg

Mkt Cap

147.38MUSD

P/E

-11.4TTM

Div Yield

–ann

52W Range

63thpctl

Volume

0.42×avg

Market Cap

147.38MUSD

P/E Ratio

-11.4TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings